VINORELBINE HIGH-AFFINITY BINDING TO HUMAN PLATELETS AND LYMPHOCYTES - DISTRIBUTION IN HUMAN BLOOD

被引:46
作者
URIEN, S
BREE, F
BREILLOUT, F
BASTIAN, G
KRIKORIAN, A
TILLEMENT, JP
机构
[1] INST CURIE,PHARMACOCINET LAB,CNRS,URA 1387,26 RUE ULM,F-75231 PARIS,FRANCE
[2] FAC MED CRETEIL,PHARMACOL LAB,F-94010 CRETEIL,FRANCE
[3] PIERRE FABRE ONCOL,PARIS,FRANCE
关键词
D O I
10.1007/BF00685841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using [H-3]-vinorelbine, we demonstrated the presence of saturable and time-dependent high-affinity binding sites on human platelets and lymphocytes. The dissociation constant and binding-site values observed were 200 +/- 38 nM, 20.0 +/- 2.2 amol/platelet, and 155 +/- 20 amol/lymphocyte, respectively. Among other blood components, saturable low-affinity binding of vinorelbine to alpha1-acid glycoprotein, serum albumin, and lipoproteins was observed. The binding to erythocytes was nonsaturable. Given die relative concentrations of these carriers, vinorelbine mainly distributes in the platelet compartment in blood (>70%), and the amount of free vinorelbine in plasma relative to the total amount in blood is <2%. It is suggested that because of the preferential retention of vinorelbine by platelets, variations in the platelet count are very likely to produce changes in the free blood fraction of vinorelbine.
引用
收藏
页码:231 / 234
页数:4
相关论文
共 11 条
[1]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9
[2]   INTERACTION OF VINBLASTINE, VINCRISTINE AND COLCHICINE WITH SERUM-PROTEINS [J].
DONIGIAN, DW ;
OWELLEN, RJ .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (17) :2113-2119
[3]   BINDING OF VINCA ALKALOID ANALOGS TO HUMAN SERUM-ALBUMIN AND TO ALPHA-1-ACID GLYCOPROTEIN [J].
FITOS, I ;
VISY, J ;
SIMONYI, M .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (03) :377-383
[4]   DIFFERENCES BETWEEN VINBLASTINE AND VINCRISTINE IN DISTRIBUTION IN BLOOD OF RATS AND BINDING BY PLATELETS AND MALIGNANT CELLS [J].
GOUT, PW ;
WIJCIK, LL ;
BEER, CT .
EUROPEAN JOURNAL OF CANCER, 1978, 14 (11) :1167-1178
[5]  
KRIKORIAN A, 1989, SEMIN ONCOL, V16, P21
[6]  
MASQUELIER M, 1986, CANCER RES, V46, P3842
[7]   THE PROTEIN-BINDING OF VINBLASTINE IN THE SERUM OF NORMAL SUBJECTS AND PATIENTS WITH HODGKINS-DISEASE [J].
STEELE, WH ;
KING, DJ ;
BARBER, HE ;
HAWKSWORTH, GM ;
DAWSON, AA ;
PETRIE, JC .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :683-687
[8]  
Tillement J.P., 1984, ADV DRUG RES, V13, P59
[9]   BINDING OF INDAPAMIDE TO SERUM-PROTEINS AND ERYTHROCYTES [J].
URIEN, S ;
RIANT, P ;
RENOUARD, A ;
COULOMB, B ;
ROCHER, I ;
TILLEMENT, JP .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (15) :2963-2966
[10]   VARIATION IN SERUM BINDING OF TERTATOLOL MEDIATED BY DISEASE-INDUCED MODIFICATION OF ALPHA-ACID GLYCOPROTEIN CONCENTRATION [J].
URIEN, S ;
MORIN, D ;
RENOUARD, A ;
ROCHER, I ;
TILLEMENT, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (04) :381-385